Member Exclusive

New funding will support development of personalized cell therapies for compromised patient populations

A Biomedical Catalyst Primer Award will fund research into low transfection efficient in patients with already highly compromised cell populations.

Thumb freya  1
Oct 10, 2017

Please sign in or register for FREE

No comments yet.